Anthropic Moves to Develop Drugs, Launching Claude Science for 60-Plus Research Databases
Updated
Updated · STAT · Jun 30
Anthropic Moves to Develop Drugs, Launching Claude Science for 60-Plus Research Databases
3 articles · Updated · STAT · Jun 30
Summary
Anthropic said Tuesday it will start developing its own drugs, extending its AI push from software tools into hands-on scientific R&D.
Eric Kauderer-Abrams, the company’s head of life sciences, said the move is meant to test Anthropic’s models on real scientific problems rather than just train models and ship products.
Claude Science debuted alongside the announcement as Anthropic’s new research workbench, giving scientists a unified environment with prebuilt tools and connections to more than 60 scientific databases.
Commercial plans remain unclear, but the effort signals Anthropic wants direct operating experience in biotech as it expands industry-specific AI products beyond general consumer use.